Contract research organizations (CRO) Market was valued at US$ 35,818.9 Mn in 2017 and is estimated to reach US$ 68,198.3 Mn by 2025. The report highlights the trends prevalent in the global CROs market and the factors driving the market along with those that act as deterrents to its growth.

Pune, India -- (SBWire) -- 03/13/2019 --The Contract Research Organization (CRO) Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

The government initiatives to increase number of clinical trial participant as well as increasing number of clinical trials in the forecast period. However, dearth of skilled professionals and extensive competition among CROs are expected to act as major challenges hindering the market growth.

Top Dominating Key Players:

1. IQVIA
2. PAREXEL International Corporation
3. Syneos Health
4. Laboratory Corporation of America Holdings
5. PRA Health Sciences, Inc.
6. Charles River
7. ICON plc
8. Pharmaceutical Product Development, LLC.
9. WuXi AppTec
10. Medpace

Get PDF Sample Copy of this Report @ https://www.theinsightpartners.com/sample/TIPBT00002008/

The Contract research organizations (CROs) include the services such as medicine and disease coding, project management, data entry & validation, clinical trial data management among others. The CROs by type, the dominance of clinical trials services segment attributes to the alleviation from large costs that are incurred by the companies for in-house activities, long duration of clinical trial phase, globalization of clinical trials, increasing number of drug discovery procedures, use of e-clinical facilities for data optimization, record & validation, and others.

The global CROs market is a matured market in the developing countries as well as developing economies worldwide. The market on the basis of type is segmented into early phase services, clinical research services, laboratory services, and post-approval services.

Clinical trial services segment led the market in 2017, and is expected to retain its dominance during the forecast period owing to the easy availability as well as affordability. On the other hand, laboratory services are expected to grow with a rapid CAGR owing to collect, combine and report the trials data from different clinical sites.

Clinical trials comprise a long duration and can require six to seven years for successful completion. These trials includes the use of placebos with randomization, and follow up of double blinded protocols to minimize biases of the drug. According to the PAREXEL Biopharmaceutical Sourcebook (2016-17), over 60% sponsors across the globe have increased outsourcing the in-house activities, majorly in terms of drug discovery and pre-clinical trial procedures. The aforementioned factors are expected to increase the market for global CROs market over the forecast period.

The report segments the global CROs market as follows:

Global CROs Market – By Type

- Early Phase Services
- Clinical Research Services
- Laboratory Services
- Post-Approval Services

Global CROs Market – By End User

- Pharmaceutical & Biotechnology Companies
- Medical Devices Companies

Purchase for Report @ https://www.theinsightpartners.com/buy/TIPBT00002008/

Reason to Buy:

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Contract Research Organization (CRO) Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Contract Research Organization (CRO), thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.